07:00 , Sep 6, 2016 |  BC Extra  |  Company News

Allergan buys gene therapy play RetroSense

Allergan plc (NYSE:AGN) acquired RetroSense Therapeutics LLC (Ann Arbor, Mich.), giving it retinitis pigmentosa (RP) candidate RST-001 . RetroSense shareholders received $60 million up front and are eligible for undisclosed regulatory and commercialization milestones. Allergan...
08:00 , Nov 16, 2015 |  BC Week In Review  |  Financial News

RetroSense Therapeutics completes venture financing

RetroSense Therapeutics LLC , Ann Arbor, Mich.   Business: Ophthalmic   Date completed: 2015-11-12   Type: Venture financing   Raised: $6 million   Investors: Blue Water Angels; RBV Capital; ExSight Capital; Santen Pharmaceutical Co. Ltd....
08:00 , Jan 12, 2015 |  BC Week In Review  |  Financial News

RetroSense Therapeutics completes venture financing

RetroSense Therapeutics LLC , Ann Arbor, Mich.   Business: Ophthalmic   Date completed: 2015-01-08   Type: Venture financing   Raised: $6 million   Investors: Nerveda LLC; Blue Water Angels; SDL Ventures; Tech Coast Angels; Michigan...